InvestorsHub Logo
Followers 6
Posts 3891
Boards Moderated 0
Alias Born 01/14/2001

Re: None

Thursday, 12/28/2006 4:45:25 AM

Thursday, December 28, 2006 4:45:25 AM

Post# of 82595
Biofrontera’s drug discovery and development projects will be combined with DNAPrint’s unique approach for the discovery of population genomics-based diagnostic tests for the improved selection of patient groups. Management expects this to facilitate the demonstration of drug efficacy and potential adverse events and accelerate selected drugs through the clinical trial process.

Ann